Restricted accessResearch articleFirst published online 2025-2
Comparative analysis of peri-nidal cerebral blood flow and metabolism using a novel quantitative 15 O-PET method in patients with arteriovenous malformations
To effectively treat cerebral arteriovenous malformations (AVMs), peri-nidal flow regulation and metabolic status must be understood. In this study, we used 15O-oxygen positron emission tomography (PET) post-processing analysis to investigate vascular radioactivity in the nidal region of AVMs. Single-dynamic PET imaging was performed on seven unruptured AVM patients during the sequential inhalation of 15O2 and C15O2. A previously validated dual-tracer basis function method (DBFM) was employed to calculate parametric images. The results of our study were as follows. First, in remote and contralateral AVM regions, DBFM and a previous approach of dual-tracer autoradiography (DARG) showed strong positive correlations in cerebral blood flow (CBF), cerebral oxygen metabolism rate (CMRO2), and oxygen extraction fraction. Second, peri-nidal CBF and CMRO2 correlation was lower, and overestimation occurred with DARG compared to with DBFM. Third, on comparing DBFM to quantitative 123I-iodoamphetamine single-photon emission computed tomography (SPECT), CBF correlated significantly. In contrast, the correlation between DARG and quantitative 123I-iodoamphetamine-SPECT was weaker in the peri-nidal regions. Fourth, analysis of tissue time-activity curves demonstrated good reproducibility using the novel formulation in the control, peri-nidus, and core nidal regions, indicating the adequacy of this approach. Overall, the DBFM approach holds promise for assessing haemodynamic alterations in patients with AVMs.
SolomonRAConnollyESJr.Arteriovenous brain malformations. N Engl J Med2017;
377: 498.
2.
MohrJPParidesMKStapfC, et al.
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (Aruba): a multicentre, non-blinded, randomised trial. Lancet2014;
383: 614–621.
3.
FukudaKMajumdarMMasoudH, et al.
Multicenter assessment of morbidity associated with cerebral arteriovenous malformation haemorrhages. J Neurointerv Surg2017;
9: 664–668.
4.
ChoiJHMastHSciaccaRR, et al.
Clinical outcome after first and recurrent haemorrhage in patients with untreated brain arteriovenous malformation. Stroke2006;
37: 1243–1247.
5.
FultsDKellyDL.Jr.Natural history of arteriovenous brain malformations: a clinical study. Neurosurgery1984;
15: 658–662.
6.
BrownRDJr.WiebersDOForbesG, et al.
The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg1988;
68: 352–357.
7.
van BeijnumJLovelockCECordonnierC, et al.
Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain2009;
132: 537–543.
8.
RodemerkJOppongMDJunkerA, et al.
Ischemia-induced inflammation in arteriovenous malformations. Neurosurg Focus2022;
53: E3.
9.
MoftakharPHauptmanJSMalkasianD, et al.
Cerebral arteriovenous malformations. Part 2: physiology. Neurosurg Focus2009;
26: E11.
10.
OkazawaHYonekuraYSadatoN, et al.
Delayed data acquisition for optimal PET activation studies with oxygen-15-water in cerebral arteriovenous malformation. J Nucl Med1995;
36: 2149–2153.
11.
KudomiNHiranoYKoshinoK, et al.
Rapid quantitative CBF and CMRO(2) measurements from a single PET scan with sequential administration of dual (15)O-labeled tracers. J Cereb Blood Flow Metab2013;
33: 440–448.
12.
IguchiSMoriguchiTYamazakiM, et al.
System evaluation of automated production and inhalation of (15)O-labeled gaseous radiopharmaceuticals for the rapid (15)O-oxygen PET examinations. EJNMMI Phys2018;
5: 37.
13.
KudomiNHayashiTTeramotoN, et al.
Rapid quantitative measurement of CMRO(2) and CBF by dual administration of (15)O-labeled oxygen and water during a single PET scan- a validation study and error analysis in anaesthetised monkeys. J Cereb Blood Flow Metab2005;
25: 1209–1224.
14.
HoriYHiranoYKoshinoK, et al.
Validity of using a 3-dimensional PET scanner during inhalation of 15O-labeled oxygen for quantitative assessment of the regional metabolic rate of oxygen in man. Phys Med Biol2014;
59: 5593–5609.
15.
IidaHItohHNakazawaM, et al.
Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med1994;
35: 2019–2030.
16.
IidaHAkutsuTEndoK, et al.
A multicenter validation of regional cerebral blood flow quantitation using [123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab1996;
16: 781–793.
17.
IidaHItohHBloomfieldPM, et al.
A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med1994;
21: 1072–1084.
18.
YokoiTIidaHItohH, et al.
A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET. J Nucl Med1993;
34: 498–505.
19.
IidaHNakagawaraJHayashidaK, et al.
Multicenter evaluation of a standardised protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine. J Nucl Med2010;
51: 1624–1631.
20.
BuchertRKlugeATossici-BoltL, et al.
Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimised for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. Eur J Nucl Med Mol Imaging2016;
43: 1323–1336.
21.
IidaHNaritaYKadoH, et al.
Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med1998;
39: 181–189.
22.
KimKMVarroneAWatabeH, et al.
Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities. J Nucl Med2003;
44: 512–519.
23.
DeloarHMWatabeHKudomiN, et al.
Dependency of energy and spatial distributions of photons on the object’s edge in brain SPECT. Ann Nucl Med2003;
17: 99–106.
24.
FujitaMVarroneAKimKM, et al.
Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET. Eur J Nucl Med Mol Imaging2004;
31: 644–654.
25.
YamauchiMImabayashiEMatsudaH, et al.
Quantitative assessment of rest and acetazolamide CBF using quantitative SPECT reconstruction and sequential administration of (123)I-iodoamphetamine: comparison among data acquired at three institutions. Ann Nucl Med2014;
28: 836–850.
26.
KimKMWatabeHHayashiT, et al.
Quantitative basal and vasareactive cerebral blood flow mapping using split-dose 123I-iodoamphetamine and single photon emission computed tomography. NeuroImage2006;
33: 1126–1135.
27.
ShimochiSIhalainenJParikkaV, et al.
Small animal PET with spontaneous inhalation of (15)O-labelled oxygen gases: longitudinal assessment of cerebral oxygen metabolism in a rat model of neonatal hypoxic-ischaemic encephalopathy. J Cereb Blood Flow Metab2023;
44: 1024–1038.
28.
MintunMARaichleMEMartinWR, et al.
Brain oxygen utilisation was measured with O-15 radiotracers and positron emission tomography. J Nucl Med1984;
25: 177–187.
29.
IidaHJonesTMiuraS.Modeling approach to eliminate the need to separate arterial plasma in oxygen-15 inhalation positron emission tomography. J Nucl Med1993;
34: 1333–1340.
30.
QuarantelliMBerkoukKPrinsterA, et al.
Integrated software for analysing brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med2004;
45: 192–201.
31.
SpetzlerRFMartinNA.A proposed grading system for arteriovenous malformations. J Neurosurg1986;
65: 476–483.
32.
IidaHHiganoSTomuraN, et al.
Evaluation of regional differences of tracer appearance time in cerebral tissues using [15O] water and dynamic positron emission tomography. J Cereb Blood Flow Metab1988;
8: 285–288.
33.
IidaHKannoIMiuraS, et al.
A determination of the regional brain/blood partition coefficient of water using dynamic positron emission tomography. J Cereb Blood Flow Metab1989;
9: 874–885.
34.
ItoHKoyamaMGotoR, et al.
Cerebral blood flow measurement with iodine-123-IMP SPECT, calibrated standard input function and venous blood sampling. J Nucl Med1995;
36: 2339–2342.
35.
MorganMKWinderMLittleNS, et al.
Delayed haemorrhage following resection of an arteriovenous malformation in the brain. J Neurosurg2003;
99: 967–971.
36.
GowersWR.A manual of disease of the nervous system.
Volume 2.
London:
J & A Churchill, 1888. 341–351.
37.
SpetzlerRFWilsonCBWeinsteinP, et al.
Normal perfusion pressure breakthrough theory. Clin Neurosurg1978;
25: 651–672.
38.
TylerJLLeblancRMeyerE, et al.
Hemodynamic and metabolic effects of cerebral arteriovenous malformations studied by positron emission tomography. Stroke1989;
20: 890–898.
39.
HomanRWDevousMDSrStokelyEM, et al.
Quantification of intracerebral steal in patients with arteriovenous malformation. Arch Neurol1986;
43: 779–785.
40.
OkabeTMeyerJSOkayasuH, et al.
Xenon-enhanced CT CBF measurements in cerebral AVM’s before and after excision. Contribution to pathogenesis and treatment. J Neurosurg1983;
59: 21–31.
41.
TarrRWJohnsonDWRutiglianoM, et al.
Use of acetazolamide-challenge xenon CT in assessing cerebral blood flow dynamics in patients with arteriovenous malformations. AJNR Am J Neuroradiol1990;
11: 441–448.
42.
MeyerBSchallerCFrenkelC, et al.
Distributions of local oxygen saturation and its response to mean arterial blood pressure changes in the cerebral cortex adjacent to arteriovenous malformations. Stroke1999;
30: 2623–2630.
43.
Hacein-BeyLNourRPile-SpellmanJ, et al.
Adaptive changes of autoregulation in chronic cerebral hypotension with arteriovenous malformations: an acetazolamide-enhanced single-photon emission CT study. AJNR Am J Neuroradiol1995;
16: 1865–1874.
44.
MastHMohrJPOsipovA, et al.
Steal’ is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke1995;
26: 1215–1220.
45.
YoungWLPile-SpellmanJProhovnikI, et al.
Evidence for adaptive autoregulatory displacement in hypotensive cortical territories adjacent to arteriovenous malformations. Columbia university AVM study project. Neurosurg1994;
34: 601–610. discussion 610–611.
46.
Al-RodhanNRSundtTMJr.PiepgrasDG, et al.
Occlusive hyperemia: a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations. J Neurosurg1993;
78: 167–175.
47.
IwamaTHayashidaKTakahashiJC, et al.
Cerebral hemodynamics and metabolism in patients with cerebral arteriovenous malformations: an evaluation using positron emission tomography scanning. J Neurosurg2002;
97: 1314–1321.
48.
FierstraJConklinJKringsT, et al.
Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. Brain2011;
134: 100–109.
49.
HashimotoNNozakiKTakagiY, et al.
Surgery of cerebral arteriovenous malformations. Neurosurg2007;
61: 375–387. discussion 387–379.
50.
SatoSKodamaNSasakiT, et al.
Perinidal dilated capillary networks in cerebral arteriovenous malformations. Neurosurg2004;
54: 163–168. discussion 168–170.
51.
SadatoNYonekuraYSendaM, et al.
PET and the autoradiographic method with continuous inhalation of oxygen-15-gas: theoretical analysis and comparison with conventional steady-state methods. J Nucl Med1993;
34: 1672–1680. 1993/10/01.
52.
LammertsmaAAJonesT.Low oxygen extraction fraction in tumours measured with the oxygen-15 steady state technique: effect of tissue heterogeneity. Br J Radiol1992;
65: 697–700.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
